DE3581691D1 - Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung. - Google Patents

Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.

Info

Publication number
DE3581691D1
DE3581691D1 DE8585113384T DE3581691T DE3581691D1 DE 3581691 D1 DE3581691 D1 DE 3581691D1 DE 8585113384 T DE8585113384 T DE 8585113384T DE 3581691 T DE3581691 T DE 3581691T DE 3581691 D1 DE3581691 D1 DE 3581691D1
Authority
DE
Germany
Prior art keywords
composition
stabilizing
inositol triphosphate
containing inositol
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585113384T
Other languages
English (en)
Inventor
Matti Siren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perstorp AB
Original Assignee
Perstorp AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8405295A external-priority patent/SE465951B/sv
Application filed by Perstorp AB filed Critical Perstorp AB
Application granted granted Critical
Publication of DE3581691D1 publication Critical patent/DE3581691D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B7/00—Preservation or chemical ripening of fruit or vegetables
    • A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
    • A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
    • A23B7/154—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3553—Organic compounds containing phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585113384T 1984-10-23 1985-10-22 Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung. Expired - Lifetime DE3581691D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8405295A SE465951B (sv) 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE8503165A SE8503165L (sv) 1984-10-23 1985-06-26 Stabilisator ii
SE8503164A SE8503164L (sv) 1984-10-23 1985-06-26 Stabilisator

Publications (1)

Publication Number Publication Date
DE3581691D1 true DE3581691D1 (de) 1991-03-14

Family

ID=27355315

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19853537563 Withdrawn DE3537563A1 (de) 1984-10-23 1985-10-22 Stabilisierte zusammensetzung mit einem gehalt an inositoltriphosphat und verfahren zu deren herstellung
DE8585113384T Expired - Lifetime DE3581691D1 (de) 1984-10-23 1985-10-22 Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19853537563 Withdrawn DE3537563A1 (de) 1984-10-23 1985-10-22 Stabilisierte zusammensetzung mit einem gehalt an inositoltriphosphat und verfahren zu deren herstellung

Country Status (7)

Country Link
US (2) US4735902A (de)
EP (1) EP0179442B1 (de)
AU (1) AU598727B2 (de)
CA (1) CA1337338C (de)
DE (2) DE3537563A1 (de)
DK (1) DK483485A (de)
GB (1) GB2167420B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128332A (en) * 1984-10-23 1992-07-07 Perstorp Ab Method of treating cardiovascular diseases using inositoltrisphosphate
US5407924A (en) * 1984-10-23 1995-04-18 Perstorp Ab Method of treating pain using inositol triphosphate
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
US5057507A (en) * 1986-04-16 1991-10-15 Perstorp Ab Method of alleviating bone damage with inositoltriphosphate
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
JPH02262584A (ja) * 1989-03-31 1990-10-25 Sanwa Kagaku Kenkyusho Co Ltd 新規組成物及びその用途
NL8902182A (nl) * 1989-08-29 1991-03-18 Unilever Nv Werkwijze voor het opwerken van vetzuren en hieruit bereide esters met een laag stolpunt.
CA2019878A1 (en) * 1989-09-13 1991-03-13 Robert Sabin Method of treatment of rheumatoid arthritis using phytic acid
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5654280A (en) * 1989-12-21 1997-08-05 Perstorp Ab Pharmaceutical composition
US20020004309A1 (en) * 1990-07-31 2002-01-10 Kenneth S. Collins Processes used in an inductively coupled plasma reactor
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US6165311A (en) 1991-06-27 2000-12-26 Applied Materials, Inc. Inductively coupled RF plasma reactor having an overhead solenoidal antenna
US6488807B1 (en) 1991-06-27 2002-12-03 Applied Materials, Inc. Magnetic confinement in a plasma reactor having an RF bias electrode
US6077384A (en) 1994-08-11 2000-06-20 Applied Materials, Inc. Plasma reactor having an inductive antenna coupling power through a parallel plate electrode
US6063233A (en) 1991-06-27 2000-05-16 Applied Materials, Inc. Thermal control apparatus for inductively coupled RF plasma reactor having an overhead solenoidal antenna
US6036877A (en) 1991-06-27 2000-03-14 Applied Materials, Inc. Plasma reactor with heated source of a polymer-hardening precursor material
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5942498A (en) * 1992-02-20 1999-08-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
US6114314A (en) * 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
TW279240B (en) 1995-08-30 1996-06-21 Applied Materials Inc Parallel-plate icp source/rf bias electrode head
US5719110A (en) * 1996-08-14 1998-02-17 Allergan Contact lens care compositions with inositol phosphate components
DE69914934T2 (de) * 1998-11-18 2005-01-05 Novo Nordisk A/S Stabile, wässrige insulin-präparate ohne phenol und cresol
US6489292B1 (en) 1998-11-18 2002-12-03 Novo Nordisk A/S Stable aqueous insulin preparations without phenol and cresol
US6401652B1 (en) 2000-05-04 2002-06-11 Applied Materials, Inc. Plasma reactor inductive coil antenna with flat surface facing the plasma
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
EP2063859B1 (de) 2006-09-13 2017-01-18 Enhance Skin Products Inc. Kosmetische zusammensetzung zur behandlung der haut und verfahren dafür
KR102306094B1 (ko) * 2018-01-19 2021-09-28 남부대학교산학협력단 프로스타좀 분비 조절용 조성물 및 이의 용도
CA3030489A1 (en) * 2018-01-19 2019-07-19 Kwang Hyun Park Composition for controlling secretion of prostasomes and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723938A (en) * 1952-12-05 1955-11-15 Bristol Lab Inc Aqueous penicillin suspensions comprising inositol phosphoric acids and their salts
JPS4423516Y1 (de) * 1965-06-26 1969-10-03
US3591665A (en) * 1967-09-08 1971-07-06 Mitsui Toatsu Chemicals Process for producing phytic acid
US4154824A (en) * 1976-07-20 1979-05-15 Interx Research Corporation Nonbitter tasting potassium product for oral administration to warm-blooded animals and method for preparing same
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
DE3614069A1 (de) * 1986-04-24 1987-11-12 Mannesmann Ag Vorrichtung zur zerstoerungsfreien pruefung durch ultraschall

Also Published As

Publication number Publication date
US4793945A (en) 1988-12-27
EP0179442A3 (en) 1987-04-08
DK483485A (da) 1986-04-24
CA1337338C (en) 1995-10-17
DK483485D0 (da) 1985-10-22
DE3537563A1 (de) 1986-05-15
US4735902A (en) 1988-04-05
GB8526081D0 (en) 1985-11-27
GB2167420A (en) 1986-05-29
AU4893385A (en) 1986-07-17
GB2167420B (en) 1988-11-09
EP0179442B1 (de) 1991-02-06
AU598727B2 (en) 1990-07-05
EP0179442A2 (de) 1986-04-30

Similar Documents

Publication Publication Date Title
DE3581691D1 (de) Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.
DE3583050D1 (de) Verfahren zur mikrophotometrie von mikroskopischen prueflingen.
DE3485206D1 (de) Verfahren zur hydroraffination von kohlenwasserstoff-einsatzmaterial.
DE3679815D1 (de) Verfahren zur innenauskleidung von leitungen.
AT384684B (de) Verfahren zur regelung von massenstroemen
PT74887B (de) Verfahren zur verbesserung der fullfahigkeit von tabaken
DE3586006D1 (de) Verfahren und zusammensetzungen zur expression von bti-endo-toxin.
ATE42273T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1diethylaminocarbonyl-2-aminomethyl-cyclopropanhydrochlorid.
DE3579641D1 (de) Verfahren und vorrichtung zur kontinuierlichen herstellung von alkoxypolysiloxanen.
AT384386B (de) Einrichtung zur handhabung bzw. positionierung von bauteilen
DE3889524D1 (de) Methode zur Stabilisierung von eingesättigten Organosilicium-Zusammensetzungen.
DE3585004D1 (de) Verfahren zur herstellung von russ.
DE3679619D1 (de) Einrichtung zur absoluten dichtebestimmung nach der auftriebsmethode.
DE3480923D1 (de) Verfahren zur c-methylierung von 2-methylbutyraten.
ATA140485A (de) Vorrichtung zur schaumveroedung von varizen
DE3874510D1 (de) Verfahren zur stabilisierung von hydroisomeraten.
DE3580634D1 (de) Verfahren zur herstellung von russ.
DE3761377D1 (de) Verfahren zur aufarbeitung von 2-merkaptobenzthiazol enthaltenden teeren.
AT372369B (de) Verfahren zur stabilisierung von alkanalen
DE3584804D1 (de) Verfahren zur oxydation von alkanen.
ATE60774T1 (de) Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.
DE3482308D1 (de) Verfahren zur radioaktiven markierung von blutzellen und zusammensetzungen dafuer.
DE3577480D1 (de) Verfahren zur stabilisierung vom ha-antigen der roeteln.
AT372499B (de) Vorrichtung zur laengsbelueftung von tunnels
AT376686B (de) Verfahren zur stabilisierung von halogenierungs- mitteln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee